Market research
OQS.F Nanosonics Limited
F EUR Healthcare
Latest close
As of 29 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 509M
- P/E ratio
- 56.67
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 1.15
Profile
Instrument facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- ISIN
- AU000000NAN9
- Market cap
- 509M
- P/E ratio
- 56.67
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 1.15
About
About Nanosonics Limited
Nanosonics Limited engages in the manufacture and commercialization of infection control and decontamination products and related technologies in Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific. It offers trophon, an automated ultrasound probe high-level disinfection device built on hydrogen peroxide chemistry with integrated digital traceability solutions, as well as related consumables and accessories. The company also provides infection control and decontamination products and related technologies. In addition, it is involved in the research, development, and commercialization of the CORIS system, an automated technology designed to transform flexible endoscope reprocessing. The company was incorporated in 2000 and is headquartered in Macquarie Park, Australia.
Research context
Nanosonics Limited appears in PyInvesting’s Frankfurt Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the OQS.F discussion.
5 years, 7 months ago
Nanosonics Limited is currently in a long term downtrend where the price is trading 16.1% below its 200 day moving average.
From a valuation standpoint, the stock is 98.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 17.6.
Nanosonics Limited's total revenue sank by 0.0% to $24M since the same quarter in the previous year.
Its net income has dropped by 0.0% to $3M since the same quarter in the previous year.
Finally, its free cash flow fell by 123.6% to $-1M since the same quarter in the previous year.
Based on the above factors, Nanosonics Limited gets an overall score of 1/5.